FDA Tussles With Combination Products, Fires Up Oncology Center Of Excellence
Executive Summary
FDA officials discuss difficulties dealing with complex combination products, the future of the agency's Centers, and promotion of industry collaboration at DIA meeting.
You may also be interested in...
US FDA May Create Immunology, Neuroscience Centers Of Excellence
Commissioner Gottlieb says new centers would follow template of Oncology Center of Excellence.
US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order
But even though executive order that requires regulatory off sets may only have limited application to FDA, limited, experts warn that it still could prove extremely unwieldly to implement.
FDA's Combo Products Review Transformation Begins
Pilot project sets timelines for lead and consulting centers that will feed into more substantial changes in PDUFA VI.